Literature DB >> 1635820

Bone mineralization outcomes in human milk-fed preterm infants.

R J Schanler1, P A Burns, S A Abrams, C Garza.   

Abstract

We evaluated bone mineralization by single photon absorptiometry at 2 y in a cohort of preterm infants studied since birth. Infants were fed human milk fortified with Ca [to achieve 80 mg/dL (19.96 mmol/L)] and P [40 mg/dL (12.91 mmol/L)] from wk 2 through 8 after birth. After hospital discharge, infants were divided into two groups (HM and F) determined by the timing of the introduction of cow milk-based formula. Mid-radius bone mineral content (BMC) was assessed in 10 infants who were breast-fed (HM) for a minimum of 2 mo after hospital discharge and 11 who were bottle-fed (F). The mean duration of human milk-feeding differed by design between HM and F groups (31 +/- 15 versus 11 +/- 3 wk, respectively). Although we had observed previously that group F had significantly greater BMC values at 16, 25, and 52 wk compared with values in group HM, we found similarities in BMC values (180 +/- 30 mg/cm) between groups at 2 y. The 2-y cohort comprised healthy infants and the groups had similar birth weights, lengths of gestation, and values for weight (10.8 +/- 1.1 kg), length (82 +/- 2 cm), and bone width (7.8 +/- 1.1 mm). Follow-up outcomes at 2 y in preterm infants fed fortified human milk in hospital suggest that if they continue to receive human milk after hospital discharge, radius BMC will "catch-up" to that of similar infants given formula in the posthospitalization period.

Entities:  

Mesh:

Year:  1992        PMID: 1635820     DOI: 10.1203/00006450-199206000-00009

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  11 in total

Review 1.  Skeletal development in premature infants: a review of bone physiology beyond nutritional aspects.

Authors:  F Rauch; E Schoenau
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-03       Impact factor: 5.747

Review 2.  Nutritional aspects of metabolic bone disease in the newborn.

Authors:  S Ryan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1996-03       Impact factor: 5.747

Review 3.  Mineral accretion in growing bones--a framework for the future?

Authors:  N J Shaw; N J Bishop
Journal:  Arch Dis Child       Date:  1995-02       Impact factor: 3.791

4.  Increased bone mineral content of preterm infants fed with a nutrient enriched formula after discharge from hospital.

Authors:  N J Bishop; F J King; A Lucas
Journal:  Arch Dis Child       Date:  1993-05       Impact factor: 3.791

5.  The association between breastfeeding, maternal smoking in utero, and birth weight with bone mass and fractures in adolescents: a 16-year longitudinal study.

Authors:  G Jones; K L Hynes; T Dwyer
Journal:  Osteoporos Int       Date:  2012-11-14       Impact factor: 4.507

Review 6.  Effects of nutrients in human milk on the recipient premature infant.

Authors:  R J Schanler; S A Atkinson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1999-07       Impact factor: 2.673

7.  Increased gain in bone mineral content of preterm infants fed an isocaloric, protein-, and mineral-enriched postdischarge formula.

Authors:  Monique van de Lagemaat; Joost Rotteveel; Mirjam M van Weissenbruch; Harrie N Lafeber
Journal:  Eur J Nutr       Date:  2012-12-18       Impact factor: 5.614

8.  Determinants of bone mass and size in 7-year-old former term, late-preterm, and preterm boys.

Authors:  H Abou Samra; D Stevens; T Binkley; B Specker
Journal:  Osteoporos Int       Date:  2009-03-24       Impact factor: 4.507

Review 9.  Exosomes in Intestinal Inflammation.

Authors:  Kanchana K Ayyar; Alan C Moss
Journal:  Front Pharmacol       Date:  2021-06-09       Impact factor: 5.810

Review 10.  Extracellular Vesicles with Possible Roles in Gut Intestinal Tract Homeostasis and IBD.

Authors:  Xin Chang; Shu-Ling Wang; Sheng-Bing Zhao; Yi-Hai Shi; Peng Pan; Lun Gu; Jun Yao; Zhao-Shen Li; Yu Bai
Journal:  Mediators Inflamm       Date:  2020-01-13       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.